Studying Walking Patterns and Fatigue in Neuromuscular Diseases
Observes walking patterns and fatigue in adults with muscle and nerve diseases.
Plain-language title generated from the registry record
Registry title: Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases
Key facts
- Where
- Bosisio Parini and Conegliano, ItalySee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06666816, who can take part
Where in Italy
- Scientific Institute IRCCS E. Medea - Sede di Bosisio PariniBosisio Parini, ItalyTaking people
- Scientific Institute IRCCS E. Medea - Polo di ConeglianoConegliano, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS Eugenio Medea
- Trial code
- NCT06666816
- Record updated
- 20 January 2026
- Original description
This study has the general objective of observing walking parameters during a clinical test to objectively estimate fatigue in patients with neuromuscular diseases. Furthermore, the investigators want to evaluate the feasibility of collecting physical activity in daily life conditions during a one-week monitoring period using a wearable sensor.Read full original descriptionShow less
Observational Study for the Identification of Fatigue and Gait Biomarkers in Populations With Neuromuscular Pathologies in the Clinical Context and Daily Life
This study has the general objective of observing walking parameters during a clinical test to objectively estimate fatigue in patients with neuromuscular diseases. Furthermore, the investigators want to evaluate the feasibility of collecting physical activity in daily life conditions during a one-week monitoring period using a wearable sensor.
Inclusion: Ambulant adult patients with genetic diagnosis of muscular dystrophy/myopathy (dystrophinopathies, muscular dystrophies and congenital and non-congenital myopathies), of spinal muscular atrophy (SMA) and with molecular diagnosis of Charcot-Marie Tooth 1 or 2; independent walking, even with assistance.
Exclusion: Dilated or ischemic heart disease with moderate impairment; Chronic respiratory failure: forced vital capacity (FVC) < 40%; more than 5% of nocturnal time spent with peripheral oxygen saturation levels < 90.